Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double Blind, (Test Products), Chronic Dosing (7 Days), Four Period, Eight Treatment , Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Five Doses of PT003, One Dose of PT001 and One Dose of PT005 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide 18 µg, Open Label) as Active Control
Brief Summary: The primary objective of this study is to assess the efficacy of Glycopyrrolate/Formoterol Fumarate MDI relative to individual components (GP MDI and FF MDI) in subjects with moderate to severe COPD


Options:
A: Arm Label: PT003 (Dose 1); Type: EXPERIMENTAL; Interventions: Drug: PT003 | Arm Label: PT003 (Dose 2); Type: EXPERIMENTAL; Interventions: Drug: PT003 | Arm Label: PT003 (Dose 3); Type: EXPERIMENTAL; Interventions: Drug: PT003 | Arm Label: PT003 (Dose 4); Type: EXPERIMENTAL; Interventions: Drug: PT003 | Arm Label: PT003 (Dose 5); Type: EXPERIMENTAL; Interventions: Drug: PT003 | Arm Label: PT001; Type: EXPERIMENTAL; Interventions: Drug: PT001 | Arm Label: PT005; Type: EXPERIMENTAL; Interventions: Drug: PT005 | Arm Label: Spiriva® Handihaler®; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tiotropium inhalation powder | Intervention Type: DRUG; Name: PT003; Assigned to Arm(s): PT003 (Dose 1), PT003 (Dose 2), PT003 (Dose 3), PT003 (Dose 4), PT003 (Dose 5) | Intervention Type: DRUG; Name: PT001; Assigned to Arm(s): PT001 | Intervention Type: DRUG; Name: PT005; Assigned to Arm(s): PT005 | Intervention Type: DRUG; Name: Tiotropium inhalation powder; Assigned to Arm(s): Spiriva® Handihaler®
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Aclidinium bromide/formoterol Fixed-Dose Combination (FDC) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Aclidinium bromide/formoterol Fixed-Dose Combination (FDC) | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aclidinium bromide | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Drug: Formoterol Fumarate | Arm Label: 5; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Aclidinium bromide/formoterol Fixed-Dose Combination (FDC); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Aclidinium bromide/formoterol Fixed-Dose Combination (FDC); Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Aclidinium bromide; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: Formoterol Fumarate; Assigned to Arm(s): 4 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 5
C: Arm Label: Olodaterol (BI 1744) Low; Type: EXPERIMENTAL; Interventions: Drug: Olodaterol (BI 1744) | Arm Label: Olodaterol (BI 1744) High; Type: EXPERIMENTAL; Interventions: Drug: Olodaterol (BI 1744) | Arm Label: Formoterol 12mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Formoterol | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Olodaterol (BI 1744); Assigned to Arm(s): Olodaterol (BI 1744) Low | Intervention Type: DRUG; Name: Olodaterol (BI 1744); Assigned to Arm(s): Olodaterol (BI 1744) High | Intervention Type: DRUG; Name: Formoterol; Assigned to Arm(s): Formoterol 12mcg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Umeclidinium 62.5 mcg + placebo; Type: EXPERIMENTAL; Interventions: Drug: Umeclidinium, Drug: Umeclidinium matching placebo | Arm Label: Tiotropium 18mcg + placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tiotropium, Drug: Tiotropium matching placebo | Intervention Type: DRUG; Name: Umeclidinium; Assigned to Arm(s): Umeclidinium 62.5 mcg + placebo | Intervention Type: DRUG; Name: Umeclidinium matching placebo; Assigned to Arm(s): Umeclidinium 62.5 mcg + placebo | Intervention Type: DRUG; Name: Tiotropium; Assigned to Arm(s): Tiotropium 18mcg + placebo | Intervention Type: DRUG; Name: Tiotropium matching placebo; Assigned to Arm(s): Tiotropium 18mcg + placebo

Answer: A